Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study

BACKGROUND: Somatostatin analogues (SSAs) are indicated to relieve carcinoid syndrome but seem to have antiproliferative effects on neuroendocrine tumours (NETs). This is the first prospective study investigating tumour stabilisation with the long-acting SSA lanreotide Autogel in patients with progr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Martín-Richard, Marta, Massutí, Bartomeu, Pineda, Eva, Alonso, Vicente, Marmol, Maribel, Castellano, Daniel, Fonseca, Emilio, Galán, Antonio, Llanos, Marta, Sala, Maria Angeles, Pericay, Carlos, Rivera, Fernando, Sastre, Javier, Segura, Ángel, Quindós, Maria, Maisonobe, Pascal
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2013
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3853091/
https://ncbi.nlm.nih.gov/pubmed/24053191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-427
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk